The price of this investment when the exchange last opened.
The highest price of this investment during regular trading hours.
The lowest price of this investment during regular trading hours.
The value of this ETF or company's issued shares based on the price of a single share multiplied by the total number of issued shares.
The highest price this investment has been in the past 52 weeks.
The lowest price this investment has been in the past 52 weeks.
The total number of shares bought and sold.
Earnings per share (EPS) is the amount of profit a company generated for each outstanding share of its common stock. It is often used as an indicator of company profitability.
Aphria, Inc. engages in the production and supply of medical cannabis. It operates through the following segments: Cannabis Operations, Distribution Operations, and Business Under Development. The Cannabis Operations segment produces, distributes, and sells both medical and adult-use cannabis. The Distribution Operations segment are carried out through its wholly owned subsidiaries ABP, FL Group, and CC Pharma. The Distribution Under Development segment includes operations in which the firm has not received final licensing or has not commenced commercial sales from operations. The company was founded by Cole Cacciavillani and John Cervini in 2013 and is headquartered in Leamington, Canada.
Irwin David Simon